Hypertension, preeclampsia and eclampsia among HIV-infected pregnant women from Latin America and Caribbean countries

Journal of Infection

Volumn 68, Issue 6, 2014, Pages 572-580

  Machado, Elizabeth Stankiewicz ^a   Krauss, Margot R ^b   Megazzini, Karen ^b   Coutinho, Conrado Milani ^c   Kreitchmann, Regis ^d   Melo, Victor Hugo ^e   Pilotto, José Henrique ^f   Ceriotto, Mariana ^g   Hofer, Cristina B ^a   Siberry, George K ^h   Watts, D Heather ^h  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b WESTAT   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Irmandade da Santa Casa de Misericordia de Porto Alegre   (Brazil)

^e FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^f HOSPITAL GERAL DE FORTALEZA   (Brazil)

^g Infectious Diseases Unit   (Argentina)

^h EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Eclampsia; HIV infected women; Hypertensive disorders; Preeclampsia; Pregnancy

Indexed keywords

CREATININE; HEMOGLOBIN;

ADULT; ARTICLE; BODY MASS; BRAZIL; CD4 LYMPHOCYTE COUNT; CONCEPTION; ECLAMPSIA AND PREECLAMPSIA; EMPLOYMENT; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HEMOCONCENTRATION; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PREGNANCY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; MAJOR CLINICAL STUDY; MARRIAGE; MATERNAL HYPERTENSION; MEDICAL HISTORY; PREGNANCY; PREGNANCY COMPLICATION; PREVALENCE; PRIMIGRAVIDA; RISK ASSESSMENT; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SOUTH AND CENTRAL AMERICA; VIRUS LOAD; YOUNG ADULT; CARIBBEAN; COHORT ANALYSIS; COMPLICATION; ECLAMPSIA; EPIDEMIOLOGY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; PRE-ECLAMPSIA; PROSPECTIVE STUDY;

ADULT; CARIBBEAN REGION; COHORT STUDIES; ECLAMPSIA; FEMALE; HIV INFECTIONS; HUMANS; HYPERTENSION; INCIDENCE; LATIN AMERICA; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84899968499     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.12.018     Document Type: Article

References (46)

1. Connor E.M., Sperling R.S., Gelber R., Kiselev P., Scott G., O'sullivan M.J., et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994, 331:1173-1180.
2. Coovadia H. Antiretroviral agents - how best to protect infants from HIV and save their mothers from AIDS. N Engl J Med 2004, 351:289-292.
3. Thorne C., Patel D., Newell M.L. Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe. AIDS 2004, 18:2337-2339.
4. Kourtis A.P., Bansil P., Mcpheeters M., Meikle S.F., Posner S.F., Jamieson D.J. Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994-2003. AIDS 2006, 20:1823-1831.
5. Kale P.L., Costa A.J.L. Maternal deaths in the city of Rio de Janeiro, Brazil, 2000-2003. J Health Popul Nutr 2009, 27:794-801.
6. Vega C.E.P., Kahhale S., Zugaib M. Maternal mortality due to arterial hypertension in São Paulo City (1995-1999). Clinics 2007, 62:679-684.
7. Lambert J.S., Watts D.H., Mofenson L., Stiehm E.R., Harris D.R., Bethel J., et al. Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. Pediatric AIDS Clinical Trials Group 185 Team. AIDS 2000, 14:1389-1399.
8. Wimalasundera R.C., Larbalestier N., Smith J.H., de Ruiter A., Mcg Thom S.A., Hughes A.D., et al. Pre-eclampsia, antiretroviral therapy, and immune reconstitution. Lancet 2002, 360:1152-1154.
9. Suy A., Martínez E., Coll O., Lonca M., Palacio M., de Lazzari E., et al. Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS 2006, 20:59-66.
10. Mattar R., Amed A.M., Lindsey P.C., Sass N., Daher S. Preeclampsia and HIV infection. Eur J Obstet Gynecol Reprod Biol 2004, 117:240-241.
11. Read J.S., Cahn P., Losso M., Pinto J., Joao E., Duarte G., et al. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites. Obstet Gynecol 2007, 109:1358-1367.
12. Centers for Disease Control and Prevention 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992, 41(RR-17):1-19.
13. Calvo E.B., Durán P., Longo E.N., Mazza C., Gilardon E.O.A. Evaluación del estado nutricional de ninas, ninos y embarazadas mediante antropometría 2009, 87-92. Ministerio de Salud de la Nación. http://www.msal.gov.ar/promin/publications/pdf/manual-nutricion-press.pdf, 1a ed.
14. Villar J., Carroli G., Wojdyla D., Abalos E., Giordano D., Ba'aqeel H., et al. Pre-eclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?. Am J Obstet Gynecol 2006, 194:921-931.
15. Gaio D.S., Schmidt M.I., Duncan B.B., Nucci L.B., Matos M.C., Branchtein L. Hypertensive disorders in pregnancy: frequency and associated factors in a cohort of Brazilian women. Hypertens Pregnancy 2001, 20:269-281.
16. Sultana R., Chen X.K., Lee C., Hader J. Outcomes in multiple gestation pregnancies among Canadian women age 35 years and older. Healthc Q 2011, 14:22-24.
17. Lamminpaa R., Vehvilainen-Julkunen K., Gissler M., Heinonen S. Preeclampsia complicated by advanced maternal age: a registry-based study on primaparous women in Finland 1997-2008. BMC Pregnancy Childbirth 2012, 12:47.
18. Ganesh K.S., Unnikrishnan B., Nagaraj K., Jayaram S. Determinants of pre-eclampsia: a case-control study in a District Hospital in South India. Indian J Community Med 2010, 35:502-505.
19. Guzman-Juarez W., Avila-Esparza M., Contretas-Solia R.E., Levario-Carrillo M. Factors associated with gestational hypertension and preeclampsia. Ginecol Obstet Mex 2012, 80:461-466.
20. Dennedy M.C., Avalos G., O'reilly M.W., O'sullivan E.P., Dunne F.P. The impact of maternal obesity on gestational outcomes. Ir Med J 2012, 105:23-25.
21. Mandal D., Manda S., Rakshi A., Dey R.P., Biswas S.C., Banerjee A. Maternal obesity and pregnancy outcome: a prospective analysis. J Assoc Physicians India 2011, 59:486-489.
22. Aardenburg R., Spaanderman M.E., Ekhart T.H., van Eijndhoven H.W., van der Heijden O.W., Peeters L.L. Low plasma volume following pregnancy complicated by pre-eclampsia predisposes for hypertensive disease in a next pregnancy. BJOG 2003, 110:1001-1006.
23. Lynch A.M., Eckel R.H., Murphy J.R., Gibbs R.S., West N.A., Giclas P.C., et al. Prepregnancy obesity and complement system activation in early pregnancy and the subsequent development of preeclampsia. Am J Obstet Gynecol 2012, 206. 428.e1-428.e8.
24. Raman L., Pawashe A.B., Yasodhara P. Hyperferritinemia in pregnancy induced hypertension and eclampsia. J Postgrad Med 1992, 38:65-67.
25. Lu J., Zhao Y.Y., Qiao J., Zhang H.J., Ge L., Wei Y. A follow-up study of women with a history of severe preeclampsia: relationship between metabolic syndrome and PE. Chin Med J (Engl) 2011, 124:775-779.
26. Hauth J.C., Clifton R.G., Roberts J.M., Myatt L., Spong C.Y., Leveno K.J., et al. Maternal insulin resistance and preeclampsia. Am J Obstet Gynecol 2011, 204. 327.e1-327.e6.
27. Zavalza-Gomez A.B. Obesity and oxidative stress: a direct link to preeclampsia?. Arch Gynecol Obstet 2011, 283:415-422.
28. Thangaratinam S., Rogozinska E., Jolly K., Glinkowski S., Roseboom T., Tomlinson J.W., et al. Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence. BMJ 2012, 344:e2088.
29. Mostello D., Jen Chang J., Allen J., Luehr L., Shyken J., Leet T. Recurrent preeclampsia: the effect of weight change between pregnancies. Obstet Gynecol 2012, 116:667-672.
30. Bridges E.J., Womble S., Wallace M., Mccartney J. Hemodynamic monitoring in high-risk obstetrics patients, I: expected hemodynamic changes in pregnancy. Crit Care Nurse 2003, 23:53-62.
31. Hytten F. Blood volume changes in normal pregnancy. Clin Haematol 1985, 14:601-612.
32. Silver H.M., Seebeck M., Carlson R. Comparison of total blood volume in normal, preeclamptic, and nonproteinuric gestational hypertensive pregnancy by simultaneous measurement of red blood cell and plasma volumes. Am J Obstet Gynecol 1998, 179:87-93.
33. Yang J.M., Yang Y.C., Wang K.G. Central and peripheral hemodynamics in severe preeclampsia. Acta Obstet Gynecol Scand 1996, 75:120-126.
34. Kalumba V.M.S., Moodley J., Naidoo T.D. Is the prevalence of pre-eclampsia affected by HIV/AIDS? A retrospective case-control study. Cardiovasc J Afr 2013, 24:24-27.
35. Conde-Agudelo A., Villar J., Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol 2008, 198:7-22.
36. Boyajian T., Shah P.S., Murphy K.E. Pregnant women receiving HAART: a matched cohort study. J Obstet Gynaecol Can 2012, 34:136-141.
37. Parekh N., Ribaudo H., Souda S., Chen J., Mmalane M., Powis K., et al. Risk factors for very preterm delivery and delivery of very-small-for-gestational-age infants among HIV-exposed and HIV-unexposed infants in Botswana. Int J Gynaecol Obstet 2011, 115:20-25.
38. Zhang C., Williams M.A., Sanchez S.E., King I.B., Ware-Jauregui S., Larrabure G., et al. Plasma concentrations of carotenoids, retinol, and tocopherols in preeclamptic and normotensive pregnant women. Am J Epidemiol 2001, 153:572-580.
39. Mawson A.R. Effects of antiretroviral therapy on occurrence of pre-eclampsia. Lancet 2003, 361:347-348.
40. Fiore S., Newell M.L., Trabattoni D., Thorne C., Gray L., Savasi V., et al. Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women. J Reprod Immunol 2006, 70:143-150.
41. Jonsson Y., Matthiesen L., Berg G., Emerudh J., Nieminen K., Ekerfelt C. Indications of an altered immune balance in pre-eclampsia: a decrease in invitro secretion of IL-5 and IL-10 from blood mononuclear cells an in blood basophil counts compared with normal pregnancy. J Reprod Immunol 2005, 66:69-84.
42. Laresgoiti-Servitje E., Gomez-Lopez N., Olson D.M. An immunological insight into the origins of pre-eclampsia. Hum Reprod Update 2010, 16:510-524.
43. Fei X., Hongxiang Z., Qi C., Daozhen C. Maternal plasma levels of endothelial dysfunction mediators including AM, CGRP, sICAM-1 and tHcy in pre-eclampsia. Adv Clin Exp Med 2012, 21:573-579.
44. Gupta S.K., Shen C., Moe S.M., Kamendulis L.M., Goldman M., Dubé M.P. Worsening endothelial function with efavirenz compared to protease inhibitors: a 12-month prospective study. PLoS One 2012, 7:e45716.
45. Savvidou M.D., Samuel M.I., Akolekar R., Poulton M., Nicolaides K.H. First trimester maternal uterine artery Doppler examination in HIV-positive women. HIV Med 2011, 12:632-636.
46. Torriani F.J., Komarow L., Parker R.A., Cotter B.R., Currier J.S., Dubé M.P., et al. Endothelial function in HIV-infected antiretroviral naïve subjects before and after starting potent antiretroviral therapy: AIDS Clinical Trials Group Study 5152s. J Am Coll Cardiol 2008, 52:569-576.